Arcturus Therapeutics is an American biotech company focused on the discovery, development and commercialization of therapeutics for rare diseases with focus on RNA. Arcturus has developed a RNA therapeutics platform called LUNAR, a proprietary lipid-enabled delivery system for RNA medicines. The company was founded in 2013 and is headquartered in San Diego, California.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Arcturus Therapeutics Holdings news
10.05.2022
Arcturus Therapeutics Holdings reported a GAAP loss of $51.169 million for the 3 months of 2022, down 9.2% from $56.346 million in the prior year. Revenue increased 2.5 times to $5.244 million from $2.127 million a year earlier.
Source: 
ir.arcturusrx.com
ir.arcturusrx.com
01.03.2022
Arcturus Therapeutics' GAAP loss in Q4 2021 was $38.664 million, up 24.3% from $31.104 million in the prior year. Revenue increased 2.6-fold to $5.794 million compared to $2.238 million a year earlier.
Source: ir.arcturusrx.com
ir.arcturusrx.com
09.11.2021
Arcturus Therapeutics Holdings' GAAP loss in Q3 2021 was $54.084 million, up 2.6 times from $21.004 million in the previous year. Revenue increased 4.5% to $2.437 million from $2.333 million a year earlier.
Source: ir.arcturusrx.com
ir.arcturusrx.com
09.08.2021
Arcturus Therapeutics Holdings' GAAP loss in Q2 2021 was $54.581 million, up 5.3 times from $10.263 million in the prior year. Revenue decreased 13.8% to $2,001 million from $2,322 million a year earlier.
Source: ir.arcturusrx.com
ir.arcturusrx.com
General information
| Company name | Arcturus Therapeutics Holdings |
|---|---|
| Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology |
| Business address | 10628 Science Center Drive San Diego, CA 92121 United States |
| Mailing address | 10628 Science Center Drive San Diego, CA 92121 United States |
| Website | ir.arcturusrx.com |
| Information disclosure | www.sec.gov |
English (US) 